We are proud to announce that West will be the 1st cancer center in the Mid‑South to offer Daraxonrasib, a next‑generation targeted therapy representing one of the most significant advances in pancreatic cancer treatment in years. Daraxonrasib is designed to interrupt key cancer‑driving pathways associated with some of the most aggressive forms of pancreatic cancer. Early clinical data has shown meaningful improvements in tumor response,… Read more »